State of Wisconsin Investment Board’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
State of Wisconsin Investment Board's STML Position: Q2 2020 in Review
State of Wisconsin Investment Board sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 78,900 shares — an estimated $382K sold.
State of Wisconsin Investment Board first reported a position in STML in Q2 2017 and held it in 12 quarters. The position peaked at $852K in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- State of Wisconsin Investment Board reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- State of Wisconsin Investment Board sold 78,900 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $382K.
- State of Wisconsin Investment Board first reported a position in Stemline Therapeutics, Inc. in Q2 2017 and held it in 12 quarters.
- State of Wisconsin Investment Board's Stemline Therapeutics, Inc. position peaked at $852K in Q2 2019.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on State of Wisconsin Investment Board's 13F filing for Q2 2020, filed 12 Aug 2020.